BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 9679066)

  • 1. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing.
    Wang J; Xiao SH; Manley JL
    Genes Dev; 1998 Jul; 12(14):2222-33. PubMed ID: 9679066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing.
    Shaw SD; Chakrabarti S; Ghosh G; Krainer AR
    PLoS One; 2007 Sep; 2(9):e854. PubMed ID: 17786225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    Tange TØ; Kjems J
    J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability.
    Wang J; Takagaki Y; Manley JL
    Genes Dev; 1996 Oct; 10(20):2588-99. PubMed ID: 8895660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
    Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
    Xiao SH; Manley JL
    Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-mRNA splicing in the absence of an SR protein RS domain.
    Zhu J; Krainer AR
    Genes Dev; 2000 Dec; 14(24):3166-78. PubMed ID: 11124808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins.
    Lemaire R; Prasad J; Kashima T; Gustafson J; Manley JL; Lafyatis R
    Genes Dev; 2002 Mar; 16(5):594-607. PubMed ID: 11877379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human splicing factor ASF/SF2 encodes for a repressor domain required for its inhibitory activity on pre-mRNA splicing.
    Dauksaite V; Akusjärvi G
    J Biol Chem; 2002 Apr; 277(15):12579-86. PubMed ID: 11801589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-mRNA splicing in plants: characterization of Ser/Arg splicing factors.
    Lopato S; Mayeda A; Krainer AR; Barta A
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3074-9. PubMed ID: 8610170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
    Tacke R; Manley JL
    EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity.
    Cáceres JF; Misteli T; Screaton GR; Spector DL; Krainer AR
    J Cell Biol; 1997 Jul; 138(2):225-38. PubMed ID: 9230067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
    Labourier E; Rossi F; Gallouzi IE; Allemand E; Divita G; Tazi J
    Nucleic Acids Res; 1998 Jun; 26(12):2955-62. PubMed ID: 9611241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
    Xiao SH; Manley JL
    EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.